Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc. could be a weak company given it's low Piotroski F-score. The momentum for this stock is not very good. Brainstorm Cell Therapeutics Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Brainstorm Cell Therapeutics Inc..

Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops and commercia...

News

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Coverage Initiated at StockNews.com

Ticker Report StockNews.com began coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI - Get Free Report) in a report issued on Saturday. The brokerage set a "hold" rating on the biotechnology company's...\n more…

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Now Covered by Analysts at StockNews.com

Zolmax StockNews.com initiated coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI - Free Report) in a research report released on Friday morning. The firm issued a hold rating on the...\n more…

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Coverage Initiated by Analysts at StockNews.com

Ticker Report Investment analysts at StockNews.com initiated coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI - Get Free Report) in a report issued on Friday. The firm set a "hold" rating on the...\n more…

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Coverage Initiated by Analysts at StockNews.com

Zolmax StockNews.com initiated coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI - Free Report) in a research note issued to investors on Thursday. The firm issued a hold rating on the...\n more…

FY2024 Earnings Forecast for Brainstorm Cell Therapeutics Inc. Issued By Zacks Small Cap (NASDAQ:BCLI)

Ticker Report Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI - Free Report) - Analysts at Zacks Small Cap decreased their FY2024 earnings per share estimates for shares of Brainstorm Cell Therapeutics in a...\n more…

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Research Coverage Started at StockNews.com

Ticker Report Equities researchers at StockNews.com assumed coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI - Get Free Report) in a research report issued to clients and investors on Thursday. The...\n more…